why choose us

First received: November 09, 2023

Clinical Trial: RT-310 Dose Escalation BPH Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: BPH (Benign Prostatic Hyperplasia)

Study Type: INTERVENTIONAL


Official Title: Safety and Feasibility Dose Escalation Study for Evaluation of RT-310 for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)

Brief Summary: RT-310, a novel implant, is intended to minimally invasive treat locally the prostate gland for the management of prostate disease, while minimizing side-effects.The objectives of the study are to assess whether RT-310 is safe and feasible for the participant population.

Read more